Delivery Order SPE2DB22D2206-SPE2DB25FHF06
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,907.08 to AmerisourceBergen Drug Corp for FOTIVDA (tivozanib) 1.34 mg capsules (21-count units) on August 21, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $15,953.54 delivery order to AmerisourceBergen Drug Corp for Fotivda 1.34 mg capsules (21-count units) under a firm fixed-price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $15,953.54 delivery order to AmerisourceBergen Drug Corp for FOTIVDA 1.34 mg capsule supply (21-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price contract is not set-aside and represents a competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FOTIVDA 0.89 mg capsules (21-count) on September 28, 2025, with a contract ceiling value of $64,177.48 and an ultimate completion date of October 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a pharmaceutical procurement supporting military and federal healthcare needs. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $15,953.54 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for FOTIVDA 1.34 mg capsules (21-count). This contract, which is non-set-aside and competitively awarded, is structured as a firm fixed price delivery order with a completion date of August 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of FOTIVDA 0.89 mg capsules (21 count), with a ceiling value of $32,270.40 and a firm fixed price structure. This non-set-aside delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FOTIVDA 0.89 MG CAPSULE 21S. The contract has a firm fixed price of $16,135.20 and a period of performance extending to July 3, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which serves as a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation. The contract, valued at $15,420.59, is for the delivery of FOTIVDA 1.34 MG CAPSULE 21S pharmaceutical products to Conshohocken, Pennsylvania. This delivery order is issued under a larger, single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value up to...
- The Defense Logistics Agency awarded a delivery order under an undisclosed contract vehicle to AmerisourceBergen Drug Corporation for the supply of 21 capsules of the pharmaceutical FOTIVDA at 0.89 mg each. Valued at $15,596.18 with a firm fixed price, the order is to be performed in Conshohocken, Pennsylvania between August 22nd and September 13th, 2023. As a major provider of medical supplies and pharmaceuticals to the U.S. military, this order for cancer treatment medication supports the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the medication FOTIVDA 0.89 MG CAPSULE 21S, with a ceiling value of $32,270.40 and a period of performance through May 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHF06Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for Fotivda 1.34 mg capsules (21-count units) with a ceiling value of $15,953.54. This firm fixed price delivery order, with an ultimate completion date of June 23, 2025, was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. Fotivda (tivozanib) is an oral tyrosine kinase inhibitor used for advanced renal cell carcinoma treatment, reflecting the breadth of specialty pharmaceutical products AmerisourceBergen supplies to support defense health systems. As a critical vendor within the Defense Health Agency's pharmaceutical supply chain, AmerisourceBergen has demonstrated substantial capability through its extensive portfolio of competitively awarded contracts ranging from small-value transactions to orders exceeding $45,000. The DLA Troop Support is transitioning to Pharmaceutical Prime Vendor Global Program Generation V contracts, potentially involving multiple regional awards, which positions AmerisourceBergen among qualified vendors to continue supplying essential medications to military healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 5/30/25 |